Introduction
In Mexico, in 70% of cases, the prostate cancer (PCa) is found in advanced stage. PCa currently occupies second place in frequency of cancer in men, surpassed only by skin cancer, and is the second principal cause of death in men after of lung cancer (Hall et al., 2005) . However, the role of these enzymes in carcinogenesis remains unclear.
On the other hand, iNOS or NOS-2 is an inducible isoform of nitric oxide synthases (NOS). All isoforms of NOS catalyze the reaction of L-arginine, NADPH and oxygen to nitric oxide (NO), L-citrulline and NADP. NO is a lipophilic physiological messenger wich regulate a variety of cellular responses and may exert its cellular action by cGMP-dependent as well as by cGMP-independent pathways (Stamler, 1994) . The expression of iNOS has been found to be increased in a variety of human cancers such as colon, stomach, brain and breasts cancers 
Patients and methods
We obtained 62 samples of prostate tissue through of various surgical procedures (transurethral resection and biopsy transrectal). Approval was obtained from the local research and ethics committee for use of tissue. Of these samples, 30 patients (48.4%) had a diagnosis of PCa, while as 32 patients (51.6%) had a diagnosis of BPH (Department of Medical Urology, Hospital Central Militar, Mexico). The sample collection was conducted from January 2006 to December 2009 and was considered inclusion, exclusion and elimination criteria. In the PCa group the average age was of 65.3 years and the concentration of preoperative PSA was of 8.6 ng/mL. In this group, the patients were classified according to Gleason scale. The score was of 4 in 1 case (3.3%), 6 in 19 cases (63.3%), 7 in 9 cases (30%) and 8 in 1 case (3.3%). None of the patients had undergone chemotherapy or radiotherapy before surgery. In the BPH group the average age was of 66.5 years and the concentration of preoperative PSA was of 8.7 ng/mL. Tissues obtained (500 mg) were stored at -83°C (Revco® Legaci ULT2186 3-35 Dupont SVVA Refrigerants) until further processing.
Immunohistochemistry
For light microscopy, tissue samples of PCa and BPH were fixed by immersion in formalin (pH 7.4) and embedded in paraffin. Serial cuts of 3 mm of thickness were mounted on poli-L-lisina coated slides (Sigma, St Louis, MO). Sections were initially deparaffinized by washing in xylene and decreasing ethanol concentrations and boiled in Declere (Cell Marque, Hot Springs, AR) to unmask antigen sites. Slides were washed in phosphate buffer saline (PBS). Endogenous peroxidase activity was blocked by exposing slides to 0.6% H2O2 in PBS for 30 min. After of washing in PBS, nonspecific binding was avoided by incubation with 5% blocking solution (5% normal goat serum in PBS) for 20 min. Sections were incubated overnight (16 h) with primary anti-p22 phox subunit NOX, anti-Mn-SOD, anti-Cu/Zn-SOD, anti-CAT, antiiNOS and anti-COX-2 antibody (1:100 for each one). Following removal of the antibodies and repetitive rinsing with PBS, slides were incubated with a biotinylated goat anti-IgG secondary antibodies (1:500 fur each one) (Jackson ImmunoReseach, West Grove, PA 
Statistics
Findings were expressed as the mean ± SD. The statistical significance of the protein expression levels of p22 phox subunit of NOX, Mn-SOD, Cu/Zn-SOD, CAT, iNOS and COX-2 between PCa and BPH groups glands or stroma, was determined using the software Prism version 3.32 (GraphPad Prism 4.0 Software, San Diego, CA, USA) with "student t-test". It was considered a p <0.05 as statistical difference between groups.
Results
The results obtained in PCa and BPH groups are summarized in In both groups was determined % area marked by field (400x) and was analized the values with significative increase in gland PCa immunoreactivity. 
Discussion
Recently, a new hypothesis has been proposed for prostate carcinogenesis. It suggested that exposure to environmental factors such as infectious agents and dietary carcinogens, and hormonal imbalances lead to injury of the prostate and to the development of chronic inflammation and regenerative 'risk factor' lesions, referred to as proliferative inflammatory atrophy (PIA). PCa is associated with oxidative stress, which stimulates the production of reactive oxidative species (ROS) and reactive nitrogen species. Oxidative stress derived from endogenous and exogenous sources are associated with DNA damage that occurs with aging and plays a role in carcinogenesis (Klein et al., 2006) . The results obtained, for the first time, in this study showed an increased in the expression of p22 phox subunit of NOX, Mn and Cu/Zn-SOD and CAT in stroma and gland of PCa. In previous studies concluded that NOX has a role as a signaling mechanism that regulates the cell growth and apoptosis in PCa (Vignais, 2002 ). Although the mechanism of COX-2 upregulation is not fully understood, it could result from activation of Ras and mitogen-activated protein kinase (MAPK) pathway. It has been recognized that Akt/PKB activity is implicated in Rasinduced expression of COX-2. COX-2 is regulated at transcriptional and post-transcriptional levels by proinflamatory agents. These pathways lead to the activation of regulatory factors that eventually bind the promoter region of the COX-2 gene. (Sheng et al., 1998 (Sheng et al., , 2000 . In this study, we found that exist strong expression of COX-2 in stroma and gland of HPB, in comparison with PCa. There are conflicting data regarding whether COX-2 is increased in the epithelial , gland or the stromal component of tumors (Horsman et al., 2010) . Liu et al were the first to describe tumorigenesis induced by COX-2 over-expression. In their study, the murine COX-2 gene was inserted downstream of a murine mammary tumor virus promoter. As a consequence, hyperplasia and carcinoma of the mammary gland were observed and associated with strong COX-2 expression in mammary gland epithelial cells with increase prostaglandin E2 levels. (Liu et al., 2001 ). The role of COX-2 in tumor promotion is more strongly supported by previous studies in colorectal tumor models describen by Oshima et al (Oshima et al., 1996) . These findings have been confirmed analyzing many tumors including pancreas, skin, gastric, bladder, lung, head, and neck cancers, suggesting that COX-2, but not COX-1, may play a pivotal role in tumor formation and growth (Thun et . We suggested that COX-2 overexpression in stroma inhibit apoptosis and promote angiogenesis in prostate gland. Our results suggest that iNOS and COX-2 play a key role in tumorigenesis and indicate that iNOS and COX-2-selective inhibitors could be a novel class of therapeutic agents for PCa.
Conclusions
We suggested that the O 2  /H 2 O 2 balance regulated by the over-expression of NOX, Cu/Zn-SOD, Mn-SOD and CAT is actively involved in tumor environment, cell proliferation, differentiation, tumor progression and angiogenesis of PCa. On the other hand, iNOS and COX-2 may promote blood vessel formation in gland from its overexpression in stroma by multiple mechanisms that involve reactive oxygen species, transcription factors, cytokines, growth factors and tumor necrosis factor. Moreover, we suggested that the NOX, Cu/Zn-SOD, Mn-SOD, CAT, iNOS and/or COX-2 in combination with PSA, could be a molecular markers or prognostic indicators for the early diagnosis and post-treatment monitoring of PCa.
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Future research
Our research group is determining the gene expression and activity of nitric oxide synthases isoforms (eNOS, nNOS and iNOS), Mn-SOD, Cu/Zn-SOD, Glutathione peroxidase, Glutathione reductase, Glutathione-S-transferase, Catalase and Ciclooxygenase-2 to integrate the effect of the regulation of the antioxidant system in the development of prostate cancer and recently in breast cancer. Actually, we begin a new line of research where we studied the gene expression and polymorphisms of some components of the cytochrome P450 system as well as its association with the risk of developing prostate cancer and breast cancer. We found a protein over-expression of CYP2W1, 4F11 and 8A1, orphans cytochromes, in prostate cancer. We hope to find a molecular marker or prognostic indicator for prostate cancer and breast cancer. www.intechopen.com
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